Table 3.
Correlations between radiographic deterioration and staining findings (neutrophil counts, IL-17, GR-β, GR-α, GR-β/GR-α, HDAC2) in ILDs (COP, sarcoidosis and IPF in combination) and IPF subgroup.
Radiograph grading CFB after OCS | ILD | p value | IPF | p value |
---|---|---|---|---|
Neutrophils/HPF | 0.12 | 0.3917 | -0.10 | 0.67 |
%IL-17 | 0.39** | 0.0067 | 0.44* | 0.0462 |
IL-17 OD | 0.48*** | 0.0006 | 0.72*** | 0.0003 |
%IL-17RA | 0.02 | 0.9153 | -0.2 | 0.4285 |
IL-17RA OD | 0.02 | 0.8917 | -0.08 | 0.7409 |
%GR-β | 0.46** | 0.0012 | 0.32 | 0.1528 |
GR-β OD | 0.50*** | 0.0003 | 0.38 | 0.0904 |
%GR-α | 0.05 | 0.7178 | 0.06 | 0.8041 |
GR-α OD | -0.20 | 0.1890 | -0.63** | 0.0021 |
%GR-β/%GR-α | 0.23 | 0.1146 | 0.09 | 0.7135 |
GR-β OD/GR-α OD | 0.57**** | < 0.0001 | 0.84**** | < 0.0001 |
%HDAC2 | 0.01 | 0.9547 | -0.11 | 0.6426 |
HDAC2 OD | -0.25 | 0.0916 | -0.28 | 0.2112 |
CXR, chest radiographic grading of the extent of disease; CFB, change from baseline; OCS, oral corticosteroids; ILD, interstitial lung diseases; COP, cryptogenic organizing pneumonia; IPF, idiopathic pulmonary fibrosis; HPF, high power fields (magnification, x400); IL-17, interleukin-17; IL-17RA, interleukin-17 receptor A; GR, glucocorticoid receptor; HDAC2, histone deacetylase 2; OD, opacity density score; *p < 0.05; **p < 0.01; ***p < 0.001; ****P < 0.0001 (Spearman’s rank correlation).